Arbor Pharmaceuticals
Pharmaceutical ManufacturingGeorgia, United States51-200 Employees
Arbor Pharmaceuticals was acquired by Azurity Pharmaceuticals in 2021. Please visit the Azurity LinkedIn page for more information.
Recent Acquisitions Arbor Pharmaceuticals has been actively acquiring other pharmaceutical companies, such as Xenoport, indicating potential opportunities for cross-selling products and services to the newly acquired customer base.
Partnership with Tasly Arbor Pharmaceuticals' partnership with Tasly Pharmaceutical Group Co., Ltd. for the R&D and marketing of T89 in the U.S. provides a strategic collaboration opportunity to leverage each other's networks and expand market reach.
New Product Launches The recent launches of Nymalize Oral Solution and Cetylev effervescent tablets present opportunities to upsell and cross-sell these innovative products to healthcare providers looking for unique pharmaceutical solutions.
Specialty Pharmaceutical Focus As a specialty pharmaceutical company, Arbor Pharmaceuticals' focus on niche markets and specialized medications opens doors for targeted sales efforts to healthcare professionals seeking specialized treatment options for their patients.
Competitive Landscape Analysis By analyzing and understanding the competitive positioning of similar companies like Alkermes, Celgene, and Biogen, Arbor Pharmaceuticals can identify gaps in the market and tailor sales strategies to differentiate its offerings and capture market share.
Arbor Pharmaceuticals uses 8 technology products and services including WordPress, Twitter Emoji (Twemoji), jQuery, and more. Explore Arbor Pharmaceuticals's tech stack below.
Arbor Pharmaceuticals Email Formats | Percentage |
First.Last@arborpharma.com | 73% |
FLast@arborpharma.com | 23% |
FirstLast@arborpharma.com | 4% |
Pharmaceutical ManufacturingGeorgia, United States51-200 Employees
Arbor Pharmaceuticals was acquired by Azurity Pharmaceuticals in 2021. Please visit the Azurity LinkedIn page for more information.
Arbor Pharmaceuticals's revenue is in the range of $10M
Arbor Pharmaceuticals's revenue is in the range of $10M